Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Gnant, M., Mlineritsch, B., Schippinger, W., Luschin-Ebengreuth, G., Pöstlberger, S., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Bjelic-Radisic, V., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806285 · Cited by 1,025
Self-citationHillner, B. E., Ingle, J. N., Chlebowski, R. T., Gralow, J., Yee, G. C., Janjan, N. A., Cauley, J. A., Blumenstein, B. A., Albain, K. S., Lipton, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.017 · Cited by 970
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Pagani, O., Regan, M. M., Walley, B. A., Fleming, G. F., Colleoni, M., Láng, I., Gomez, H. L., Tondini, C., Burstein, H. J., Perez, E. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404037 · Cited by 749
Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Heck, D., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Pristauz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70122-x · Cited by 472
Self-citationBreast-Cancer Adjuvant Therapy with Zoledronic Acid
Coleman, R. E., Marshall, H., Cameron, D., Dodwell, D., Burkinshaw, R., Keane, M., Gil, M., Houston, S. J., Grieve, R. J., Barrett-Lee, P. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105195 · Cited by 424
Breast-cancer Adjuvant Therapy With Zoledronic Acid
Coleman, R. E., Marshall, H. C., Cameron, D., et al. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 413
Gnant, M., Mlineritsch, B., Luschin-Ebengreuth, G., Kainberger, F., Kässmann, H., Piswanger-Sölkner, J. C., Seifert, M., Ploner, F., Menzel, C., Dubsky, P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70204-3 · Cited by 396
Self-citationColeman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., von Minckwitz, G., Sleeboom, H. P., Forbes, J., Barrios, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds277 · Cited by 339
Self-citationEidtmann, H., de Boer, R., Bundred, N., Llombart-Cussac, A., Davidson, N., Neven, P., von Minckwitz, G., Miller, J., Schenk, N., & Coleman, R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq217 · Cited by 281
Self-citationExploring the anti-tumour activity of bisphosphonates in early breast cancer
Winter, M. C., Holen, I., & Coleman, R. E. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.02.004 · Cited by 224
Pfeiler, G., Königsberg, R., Fesl, C., Mlineritsch, B., Stoeger, H., Singer, C. F., Pöstlberger, S., Steger, G. G., Seifert, M., Dubsky, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2585 · Cited by 221
Self-citationPaterson, A. H., Anderson, S. J., Lembersky, B. C., Fehrenbacher, L., Falkson, C. I., King, K. M., Weir, L. M., Brufsky, A. M., Dakhil, S., Lad, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70226-7 · Cited by 194
Brufsky, A. M., Harker, W. G., Beck, J. T., Bosserman, L., Vogel, C., Seidler, C., Jin, L., Warsi, G., Argonza‐Aviles, E., Hohneker, J., et al. (2012) · Cancer · doi:10.1002/cncr.26313 · Cited by 192
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
Chlebowski, R. T., Chen, Z., Cauley, J. A., Anderson, G., Rodabough, R. J., McTiernan, A., Lane, D. S., Manson, J. E., Snetselaar, L., Yasmeen, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.2095 · Cited by 187
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
Coleman, R., Gnant, M., Morgan, G., & Clezardin, P. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs263 · Cited by 184
Self-citationSt. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion
Harbeck, N., Thomssen, C., & Gnant, M. (2013) · Breast Care · doi:10.1159/000351193 · Cited by 174
Self-citationDirect and indirect anticancer activity of bisphosphonates: A brief review of published literature
Gnant, M., & Clézardin, P. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.09.003 · Cited by 168
Self-citationBisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
Newcomb, P. A., Trentham‐Dietz, A., & Hampton, J. M. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605555 · Cited by 126
von Minckwitz, G., Möbus, V. J., Schneeweiß, A., Huober, J., Thomssen, C., Untch, M., Jackisch, C., Diel, I., Elling, D., Conrad, B., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.2167 · Cited by 110
Fogelman, I., Blake, G. M., Blamey, R. W., Palmer, M. K., Sauerbrei, W., Schumacher, M. C., Serin, D., Stewart, A., & Wilpshaar, W. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1508-y · Cited by 109
Shapiro, C. L., Halabi, S., Hárs, V., Archer, L. E., Weckstein, D. J., Kirshner, J. J., Sikov, W. M., Winer, E. P., Burstein, H. J., Hudis, C. A., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.024 · Cited by 102
Prolonged Efficacy of a Single Dose of the Bisphosphonate Zoledronic Acid
Brown, J. E., Ellis, S. P., Lester, J., Gutcher, S. A., Khanna, T., Purohit, O. P.-K., McCloskey, E. V., & Coleman, R. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0247 · Cited by 80
Kristensen, B., Ejlertsen, B., Mouridsen, H. T., Jensen, M., ANDERSEN, J. E., Jensen, B. B., Cold, S., Edlund, P., Ewertz, M., Kamby, C., et al. (2008) · Acta Oncologica · doi:10.1080/02841860801964988 · Cited by 70
Bone turnover across the menopause transition: The role of gonadal inhibins
Nicks, K. M., Fowler, T. W., Akel, N. S., Perrien, D. S., Suva, L. J., & Gaddy, D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05349.x · Cited by 49
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Self-citationHarbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
Self-citationCoates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, F., Baselga, J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,827
Self-citationCurigliano, G., Burstein, H. J., Winer, E. P., Gnant, M., Dubsky, P., Loibl, S., Colleoni, M., Regan, M. M., Piccart-Gebhart, M., Senn, H.-J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx308 · Cited by 1,205
Self-citationRuggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D. (2022) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2022.02.008 · Cited by 1,141
Metadata
- Authors
- Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Knauer, M., Moik, M., Jakesz, R., Seifert, M., Taucher, S., Bjelic-Radisic, V., Balic, M., Eidtmann, H., Eiermann, W., Steger, G., Kwasny, W., Dubsky, P., Selim, U., Fitzal, F., Hochreiner, G., Wette, V., Sevelda, P., Ploner, F., Bartsch, R., Fesl, C., & Greil, R.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 26
- Issue
- 2
- Pages
- 313-320
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2127286421
- Cited by
- 312
- References
- 25
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.